This past Saturday, Innocan Pharma Corporation (OTCMKTS:INNPF), a pharmaceutical technology firm, was in the news after it came up with a significant new announcement. The company which specializes in drug delivery platform technologies and owns an intellectual property portfolio, announced that it had been issued a Notice of Allowance by the United States Patent and Trademark Office for one of its patents.
Trading Data
On Friday, INNPF stock ended flat at $0.2220 with more than 6K shares, compared to its average volume of 201 shares. The stock moved within a range of $0.2220 – 0.2220 after opening trade at $0.2213.
Innocan Pharma Announces First Patent Grant in the United States
The patent in question is related to the combined cannabis and magnesium tropical pain relief technology that had been created by Innocan Pharma. As per the patent application, it was claimed by the company that the magnesium and cannabis based technology, which is supposed to be administered topically, was a major breakthrough.
The technology was created by Innocan Pharma in such a way that it could help in providing systemic relief from pain as well as itching. It could be applied through lotions, roll-on or spray. Innocan Pharma is currently looking to apply for more patent applications for its unique cannabis based intellectual property portfolio with both the United States Patent and Trademark Office as well as with patent offices in different parts of the world. That would help the company in further establishing its portfolio of products.
